Beatrice Alexandra Golomb, MD, PhD


GULF WAR LINKS


Beatrice A. Golomb, Acetylcholinesterase inhibitors and Gulf War illnesses,

Proceedings of the National Academy of Sciences,  vol. 105, pp 4295-4300  March 18, 2008.


Early edition:

http://www.pnas.org/papbyrecent.shtml


Previous Study:


Pyridostigmine Bromide: A Review of the Scientific Literature as it Pertains to Gulf War Illnesses 

http://www.amazon.com/Pyridostigmine-Bromide-Scientific-Literature-Illnesses/dp/0833026771/ref=sr_1_2?ie=UTF8&s=books&qid=1205197148&sr=8-2


STATIN STUDY


https://www.statineffects.com/info



CURRICULUM VITAE

Beatrice Alexandra Golomb, MD, PhD

Dept of Medicine 09955

9500 Gilman Dr. La Jolla CA 92093-0995

Phone: (858) 558-4950 x201

Fax: (858) 558-4960

Email: bgolomb@ucsd.edu


http://www.statineffects.com


CURRENT POSITIONS

Associate Professor of Medicine: July 2004 - present

Division of General Internal Medicine

University of California, San Diego School of Medicine 


Associate Professor of Family and Preventive Medicine: July 2004-present

University of California, San Diego School of Medicine 


Research Associate Professor: October 1998 – present

Department of Psychology

Social Science Research Institute

University of Southern California


Attending Physician: August 1996 – present

Division of General Internal Medicine 

VA San Diego Healthcare System


Health Consultant, RAND: August 1996 - present

Santa Monica, CA 


Robert Wood Johnson Generalist Physician Faculty Scholar: July 2003 – 2007 


EDUCATION AND TRAINING

Robert Wood Johnson Clinical Scholar, UCLA: 1994 - 1996

Chief Medical Resident, West Los Angeles VA Medical Center: 1993 - 1994

Medical Resident, West Los Angeles VA Medical Center: 1990 - 1993

Postdoctoral Fellow, Computational Neurobiology Laboratory, Salk Institute: 1989 - 1990

MD, University of California, San Diego: June 1989

PhD, Biology, University of California, San Diego: June 1988

Medical Scientist Training Program, University of California, San Diego: June 1979

BS, Physics, Summa Cum Laude (4.0 GPA at age 19), University of Southern California: 1979

Physics graduate fellowship offers (declined), Harvard University and California Institute of Technology: 1979


PAST APPOINTMENTS

Assistant Professor, Dept. of Family and Preventive Medicine, UC San Diego: July 2002 – 2004

Assistant Professor, Dept. of Psychology, UC San Diego: July 2001 - 2004

Assistant Professor of Medicine, UC San Diego: April 1998 - July 2004

Research Assistant Professor, Dept. of Psychology, USC: June 1995 – 1998

Teaching Assistant, Cell Biology, UCSD Department of Biology: 1987; Physiology of Sensation and Perception, UCSD Department of Psychology: 1987; Endocrinology, UCSD Department of Biology: 1986; Neurobiology, UCSD Department of Biology: 1985; Genetics, UCSD Department of Biology: 1983, 1984

Jet Propulsion Laboratory, Engineer I: 1979

Jet Propulsion Laboratory, Technical Aide A: 1978


LICENSURE California, Issued October 8, 1991


BOARD CERTIFICATION American Board of Internal Medicine, September 1993


AWARDS, HONORS, FELLOWSHIPS

Robert Wood Johnson Generalist Physician Faculty Scholar Award: 2003-2007

Who’s Who in America: 2000 - present

Fellow, AHA Council on Epidemiology and Prevention: 2000 - present

Fellow of the American Heart Association: July 2001

Associate Fellow, American Heart Association Council on Epidemiology and Prevention: elected March 25, 1999

Fellow, 23rd Annual American Heart Association 10-day Seminar on the Epidemiology and Prevention of Cardiovascular Diseases: 1997

Solomon Scholar Research Award, UCLA: 1992, 1993

Emma Josephine Bradley Bovard Award (for graduating USC senior with best academic record): 1979

Phi Kappa Phi: 1979

Junior Phi Beta Kappa: 1978


PROFESSIONAL ACTIVITIES AND AFFILIATIONS

Scientific Director, Department of Veterans Affairs Research Advisory Committee on Gulf War Veterans Illnesses: Jan 2002 - Sep 2003; Chief Scientist: Sep 2003 – 2005; Member 2005-present

Member, Committee on Appointments and Promotions (DOMCAP), UCSD 2007-2010

Peer Review Grants, International Coenzyme Q10 Association, 2007

Advisory Board. Doctor Evidence (www.doctorevidence.com), 11-07 to present

Advisory Board, The Science Network (http://www.tsntv.org/about/advisors.php): 2004 – present

Senior Vice President, ISCHEM Corp: 2002 – present

Co-Organizer, Robert Wood Johnson Generalist Physician Faculty Scholar Program, premeeting 11-28-07, Coronado, CA

Planning Committee, Robert Wood Johnson Generalist Physician Faculty Scholar Program Annual Meeting (San Diego) 11-27 to 11-30 2007, Coronado, CA

Organizer, Robert Wood Johnson Generalist Physician Faculty Scholar Program (premeeting + meeting 11-29-06). Ft Lauderdale, CA

Planning Committee, Robert Wood Johnson Generalist Physician Faculty Scholar Program 2006 annual meeting (premeeting + meeting 11-28-06 to 12-1-06, Ft. Lauderdale)

Invited Nominator, Edge of Computation Science Prize (2005) http://www.edge.org/3rd_culture/prize05/prize05_index.html

Member, American Society for Preventive Cardiology: 2002 - present

Member, Stein Institute for Research on Aging: Aug 2001 – present

Pharmacy and Therapeutics Committee, VA San Diego Medical Center: 2001 – 2005

Member, AHA Council on Epidemiology and Prevention: 2000 – present

Member, American College of Physicians: March 1995 – present

Family and Preventive Medicine (FPM) 221: Preventive Cardiopulmonary Risk Factor Assessment (annually 1999-2005) Participated annually as faculty, director of blood pressure testing component; and have lectured on cardiopulmonary risk factors 

Attending physician, Emergency Room, West Los Angeles VA Medical Center: 1994 - 1997

Pharmacy and Therapeutics Committee, WLA VA Medical Center, 1993-1994

Ethics Committee, West LA VA Medical Center, 1991-1994

Judge, Performance Improvement Fair, VASDMC: May 2001 – May 2006

Peer Review, journals including: Annals of Internal Med, New Engl J Med, JAMA, Lancet, BMJ, Circulation, JACC, Am J Med, J Gen Internal Med, Medical Care, Tohoku J Exp Med, J Women’s Health, J Clin Epi, Am J Epi, Ann Epi, Contemp Clin Trials, Ann Behav Med, Psychosomatic Med, Psychiatric Services, Psychiatry Research, Biological Psychiatry, J Affective Disorders, Ann Surg, Neuropsychopharmacology, Muscle and Nerve, Am J Primatology, Complex Systems, Evolutionary Anthropology, Eur J Pharmacol, others.

(Received letters from Annals Int Med in 2006 and 2007 that I was rated among the top 10 reviewers of the prior year.)

Peer Review participation, Books: Oxford University Press


OTHER

Accompanied high level mission to the Middle East, with Dr. Bernard Rostker (Assistant Secretary of Defense for Personnel and Manpower; then Undersecretary of the Navy), and several other DoD and Congress officials. Purpose: to brief officials from other nations regarding illness in Gulf War veterans and exposures in Persian Gulf War; and to perform fact collection; itinerary included Kuwait, Saudi Arabia, Egypt, and Israel: Oct 1997 – Nov 1997



RESEARCH GRANTS

Funded: Department of Defense Gulf War Veterans’ Illnesses Research Program Grant 

Project Title: Q10 for Gulf War Veterans

Project Number: GW060036 

Amount: $718,261.53 (total to include indirect costs) 

Dates: 9/30/2007 - 9/29/2010

Principle Investigator: Beatrice A. Golomb


Funded: NIH R34

Project Title: Coenzyme Q10 in Aging: A Planning Grant

Project Number: 1 R34 AG026338

Amount: $100,000 (total to include indirect costs)

Dates: Aug 2005 - July 2007

Principal Investigator: Beatrice A. Golomb


Funded: RWJ Generalist Physician Faculty Scholar Award

Project title: Enhancing Postmarketing Drug Adverse Event Surveillance Through the

Internet: Statin Cholesterol Lowering Drugs

Amount: $300,000 (total direct costs over 4 years)

Dates: July 2003 - 2007


Funded: NIH RO1

Project Title: Statins and Noncardiovascular Endpoints

Project Number: 98-1060

Amount (Total direct costs over 5 years) $4.19 million

Dates: Aug 1999 - July 2006

Principal Investigator: Beatrice A. Golomb

Administrative Supplement to the above

Amount (Total direct costs): $300,000

Dates: Aug 2001 – Aug 2003 


Funded: Academic Senate Interdisciplinary Course Development Award

Project Title: Course: Evaluation of Evidence and Inference

Amount: $9,000 (covers 50% graduate student x 2 quarters)

Dates: July 2001 - Jan 2002


Funded: Harry Frank Guggenheim Foundation

Project Title: Low Serum Cholesterol and Violent Behavior

Amount: $30,000 per annum

Dates: Jan 1996 – Jan 1998

Principal Investigator: Beatrice A. Golomb


EXPERT PANEL PARTICIPATION

Department of Veterans Affairs, Research Advisory Committee on Gulf War Illnesses: Jan 2002 – present.

Expert panelist for NIH (NHLBI) Program Project Review. February 2007.

Expert panelist for NIH (NHLBI) Review Panel on "Prevention of Cardiovascular Disease in Diabetes Mellitus: Clinical Center Network Proposals": June 1999.

Expert "panelist" for the Department of Defense in the Army After Next AMEDD Technical Workshop to advise strategies for troop health protection in the year 2025. MacLean, Virginia: June 13 1999 – June 18 1999.

Expert panelist for the Center for Health Policy Research/Health Care Financing Association “Normative Standards Project”, pertaining to normative standards for home health care (requested; participation aborted due to date conflict with Department of Defense panel above): June 1999.

Panelist and speaker at event sponsored by the Violence Prevention Coalition of Greater Los Angeles entitled "How might interdisciplinary models of research guide us to a better understanding of violence?" Los Angeles, CA: Nov 1998.


BRIEFINGS TO GOVERNMENT AGENCIES

“Oxidative stress, mitochondria, and illness in Gulf War veterans: A hypothesis.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: April 24, 2007.

“Statin Side Effects.” Invited discussion with Senate Finance Committee representatives. Dickson Building, Capitol Hill, Washington DC: June 9, 2006.

“Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: May 16, 2006.

“Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: April 8, 2005.

“Gulf War Illnesses, Anthrax Vaccine.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: April 7, 2005.

 “Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: June 29, 2004.

“Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: Feb 23, 2004.

“Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: June 2003.

“Birth Defects in Gulf War Veterans, Gulf War Veterans Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: June 2003.

“Candidate Research Recommendations”, “Vaccines and illness in Gulf War Veterans”, Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: Feb 2003.

“Gulf War Veterans Illnesses, Research Update focusing on Acetylcholinesterase inhibitors.” Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: Feb 2003.

“Treatments for Gulf War Veterans: What has been tried, and what are candidate treatments?” “Vaccines and illness in Gulf War Veterans.” Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: Oct 2002.

“Vaccines and illness in Gulf War Veterans.” Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: Oct 2002.

"Acetylcholinesterase inhibitors and illness in Gulf War veterans." Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: June 26, 2002.

"Treatments for ill Gulf War veterans." Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: Feb 2002.

"Pyridostigmine Bromide: A Review of the Scientific Literature as it Pertain to Gulf War Illnesses." Testimony to Congress: House Veterans Affairs Committee, Health Subcommittee and Benefits Subcommittee. Washington DC: Nov 19, 1999.

Briefings to members of Senate subcommittees (Foreign Affairs and Veterans Affairs). Washington DC: Oct 19, 1999.

"Pyridostigmine Bromide: A Review of the Scientific Literature as it Pertain to Gulf War Illnesses." Briefing to representatives of multiple U.S. Veterans advocacy groups. Washington DC: Oct 19, 1999.

"Pyridostigmine Bromide: A Review of the Scientific Literature as it Pertain to Gulf War Illnesses." Press Briefing from the Pentagon. Washington DC: Oct 19, 1999.

"Pyridostigmine bromide and illness in Persian Gulf War veterans." Briefing to group consisting of: the Undersecretary of Health, the Undersecretary of the Army, the Surgeon General of the Army, the Principal Deputy for Health Affairs, representatives from the Surgeons General of the Navy and Air Force, several other generals, and the Directors of the Health and Defense Programs at RAND (The group convened for the exclusive purpose of hearing my briefing). Washington DC: Feb 3, 1998.

"RAND on PB and Immunizations." Presidential Special Oversight Board for Department of Defense Investigations of Gulf War Chemical and Biological Incidents. Arlington, VA: Oct 28, 1998.

"RAND Center for Military Health Policy Research: Gulf War Illness." (with Dr. Ross Anthony) Briefing to Major General James B. Peake, Commanding General/Commandant/ Installation Commander, US Army Medical Department Center and School. RAND Arroyo Center, Army Research Division. Santa Monica, CA: Oct 22, 1998.

"Health Effects of Service in the Gulf War." (with Dr. Ross Anthony) Briefing to DARPA and DSO (Defense Science Office. Arlington, VA: Sept 8, 1998.

"Health Effects of Service in the Gulf War." (with Dr. Ross Anthony) Briefing to Advisory Board of the National Defense Research Institute. RAND. Santa Monica, CA: May 5, 1998.

"Health Effects of Service in the Gulf War." (with Dr. Ross Anthony) Briefing to RAND Board of Trustees RAND’s 50th birthday. Washington DC: April 9, 1998.

"Pyridostigmine bromide and illness in Persian Gulf War veterans." Briefing to representatives from DoD, VA, FDA, PAC, and Congress. RAND Washington, Washington DC: Nov 4, 1997.

"Pyridostigmine bromide." Briefing to Israeli Defense and Health personnel, as part of a mission to the Middle East with Dr. Bernard Rostker (Assistant Secretary of the Navy; now Undersecretary of the Army) and others from the DoD. Tel Aviv, Israel: Nov 1 1997 (Participated in other briefings in the Middle East - Kuwait, Saudi Arabia, and Egypt - during a ~2 week trip).

Other Research Advisory Committee on Gulf War Veterans Illnesses Meetings Attended: Aug 13-15, 2006; Nov 5-6, 2006.


LECTURES, PRESENTATIONS 

(See also Briefings to Government Agencies; and Abstracts)

“Dissent in Medicine: Stacking the Deck.” London School of Economics/UCSD Science Studies Program Dissent in Science: Origins and Outcomes Workshop, La Jolla, CA: Mar 3 2008. (Sponsored by AHRC (UK) as part of the Contingency and Dissent in Science project at the CPNSS, London School of Economics)

“Stacking the Deck: Drug Risks and Benefits.” Health Services Research & Development Scholarly Conference, Veterans Affairs San Diego Healthcare System, La Jolla CA: Feb 22, 2008.

“Evidence Based Diet” UCSD School of Medicine SOM410, From Principles to Practice, La Jolla, CA: Feb.19, 2008.

“Stacking the Deck: Treatment Risks and Benefits.” General Internal Medicine Grand Rounds, UCSD School of Medicine, La Jolla, CA: Jan. 30, 2008.  

“Simvastatin But Not Pravastatin Affects Sleep: Findings from the UCSD Statin Study.” American Heart Association annual meeting, oral presentation, Orlando, FL: Nov. 7, 2007.

“Statins: Risks and Benefits.” Grand Rounds, Scripps Green Hospital. La Jolla, CA: June 27, 2007.

“Statin side effects. A mitochondrial connection?” Invited talk, UC Irvine MitoMed group (mitochondrial medicine), Irvine, CA: June 18, 2007.

“Cholesterol, Heart Disease, and You.” UCSD Health and Wellness Series, Price Center, UCSD. La Jolla, CA: May 22, 2007.

“Statin Side Effects.” Invited Lecture, American College for Advancement in Medicine. Chicago, IL: May 13, 2007.

“Mitochondrial Dysfunction and Illness in Gulf War Veterans.” Research Advisory Committee on Gulf War Illness. Department of Veterans Affairs, Washington D.C.: April 24, 2007.

“Enhancing Post-marketing Drug Surveillance: A Response to Expressed Needs of Patients.” Robert Wood Johnson Foundation Generalist Physician Faculty Scholars Program Annual Meeting oral presentation, San Antonio, TX: Dec 1, 2006.

“Do Low Dose Statins Affect Cognition? Results of the UCSD Statin Study.” American Heart Association oral presentation, Chicago, IL: Nov. 15, 2006.

“Ethical Reasoning in Medicine – or the Contrary?” UCSD School of Medicine Biomedical Ethics Seminar: Sept 20, 2006.

“Stacking the Deck.” Health Services Research & Development, VA San Diego Healthcare Center. La Jolla, CA: July 20, 2006.

“Gulf War Illness.” VA San Diego Healthcare Center. La Jolla, CA: April 14, 2006

“Do statins cause long term adverse effects?” Invited talk followed by invited panelist discussion, Panel: Controversies in Lipid Lowering Therapy, American College of Cardiology meeting. Atlanta, Georgia: March 12, 2006.

“Cholesterol and Violence.” Invited talk, San Diego Superior Court. San Diego, CA: Feb 7, 2006. 

“Peer Review.” Invited talk, VA San Diego Healthcare center. La Jolla, CA: Dec 9 2005. 

“Patient Targeted Adverse Event Surveillance: Use for Hypothesis Generation.” Robert Wood Johnson Generalist Physician Faculty Scholar meeting. Ft. Lauderdale, FL: Nov 10, 2005.

“Should statins be put in the water supply?” Distinguished Visitor Programme speaker, Biomedical Research Council, Agency for Science, Technology and Research (ASTAR). Singapore: Oct 25, 2005.

“Bridging the basic science/clinical science gap”. MSTP (Medical Scientist Training program -- MD/PhD program) retreat roundtable presentation. Aug 27, 2005. 

“Conflict of interest”; CREST (Clinical Research Enhancement Through Supplemental Training, http://crest.ucsd.edu), Patient Oriented Research II: Ethics and regulation of human research. San Diego, CA: Aug 17, 2005; La Jolla, CA: Aug 18, 2005. 

“A Scientific Career.” McNair Summer Research Program, UCSD. La Jolla, CA: July 2005.

“Clinical follow-up after stopping statin treatment.” Fourth Conference of the International Coenzyme Q10 Association. Los Angeles, CA: April 2005.

"Lack of Physician Response Toward Perceived Statin Adverse Events." 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in association with the Council on Nutrition, Physical Activity and Metabolism. April 2005.

“Drug benefits and harms: Stacking the deck.” Science Policy Analysis Roundtable series (http://acs.ucsd.edu/~spar/), UCSD. La Jolla, CA: March 10, 2005. 

“Adverse Drug Effects: The Case of Statins.” UCSD Biomedical Ethics Seminar Series, UCSD. La Jolla: CA. Feb 16, 2005.

“Coenzyme Q10, Mitochondrial Function, Statins, and Aging.” Stein Institute for Research on Aging Grand Rounds, UCSD. La Jolla, CA: Jan 10, 2005. 

“Should Statins be Put in the Water Supply?” Dept of Medicine, Yale. Newhaven, CT: July 21, 2004.

“CNS effects of low cholesterol.” UCSD Dept of Biology colloquium. La Jolla, CA: April 2004.

“Cholesterol and the brain”. UCSD Dept of Psychology colloquium. La Jolla, CA: March 16, 2004.

“Should statins be put in the water supply?” CTF C 301, UCSD. La Jolla, CA: March 10, 2004. 

“Cholesterol and the brain: Mood, violence, and cognition.” Dept of Psychology, University of Southern California. Los Angeles, CA: Feb 11, 2004. 

“Cardiovascular Prevention: Putting the Risk in Risk Benefit.” Department of Preventive Medicine, SUNY. Stonybrook, NY: Jan 27, 2004.

“The Great Debate. Do benefits of statins as currently used exceed the risks?” (with debaters John H. Lehman, John Robin Crouse and Michael J. Davidson) American College of Toxicology Annual Meeting. Washington DC: Nov 4, 2003. 

“Anthrax Vaccine: Is it safe? Is it effective?” VA Faculty Development Seminar Series. La Jolla, CA: June 15, 2003.

"The Anthrax Vaccine: Is it safe and effective?" Epidemiology conference, Family and Preventive Medicine. La Jolla, CA: April 7, 2003.

"Research Recommendations: Focus on Acetylcholinesterase Mechanisms." Presentation to the Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses. Washington DC: Feb 2003.

"Recent Gulf War Illnesses Research." Presentation to the Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses/ Washington DC: Feb 2003.

"Acetylcholinesterase inhibitors and Gulf War Illnesses." Presentation to the Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses. Washington DC: Nov 2002.

"Gulf War veterans illnesses: Treatment issues." Presentation to the Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses. Washington DC: Nov 2002. 

"Mitochondrial function and Gulf War Illnesses." Presentation to the Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses. Washington DC: Nov 2002.

"A new perspective on cholesterol, statins, and heart disease." Stein Institute for Aging public lecture (televised for UCSD TV), La Jolla, CA: Aug 21, 2002. 

"Putting the risk in risk benefit analysis." Dept of Medicine, Stonybrook School of Medicine. Stonybrook, NY: July 16, 2002.

AHA Debate: "Controversies in Preventive Cardiology Debate: NCEP ATP III Guidelines have not gone far enough."  Pro: Dr. John Robin Crouse. Con: Dr. Beatrice A. Golomb. American Heart Association Council on Epidemiology and Prevention, and American Society for Preventive Cardiology, 42nd Annual Conference on Cardiovascular Disease Epidemiology and Prevention. Honolulu, Hawaii: April 26, 2001.

"Cholesterol and Mood", UCSD Family & Preventive Medicine monthly conference, La Jolla, CA: Jan 15, 2002.

"The Angina Monologues", American Association of University Women: Oct 20, 2001. 

"Restoring the risk to risk benefit analysis", Faculty Development series, VA San Diego Healthcare Center, La Jolla, CA: Oct 12, 2001.

"Syndromes without objective findings," 3rd Annual Federal Workers’ Compensation Conference, Chicago, IL: April 23, 2001.

"Cholesterol and Violence", UCSD Medical Scientist Training Program conference series, La Jolla, CA: Aug 6, 2001. 

"Cholesterol," Rancho Carlsbad Health Fair, Carlsbad, CA: July 16, 2001.

"Cholesterol," VASDHS morning conference series, La Jolla, CA: June 15, 2001. 

"Cholesterol and you," Plan for Wellness II, UCSD sponsored community lecture series, Mission Valley, La Jolla, CA: May 20, 2001.

"Stroke," Aging in the New Millenium, Academic Geriatric Resource Center, UCSD School of Medicine, La Jolla, CA: May 19, 2001. 

"Cardiovascular Disease," Aging in the New Millenium, Academic Geriatric Resource Center, UCSD School of Medicine, La Jolla, CA: May 19, 2001. 

"Hyperlipidemia," VASDHS morning conference series, La Jolla, CA: April 18, 2001. 

"Statins and cognitive function," VASDHS morning conference, La Jolla, CA: March 16, 2001. 

"Cholesterol and lipids," lecture to first year UCSD medical students, La Jolla, CA: Dec. 4, 2000. 

"Putting the risk in risk-benefit analysis for cardiovascular disease," invited talk, American Heart Association, Annual Investigators Meeting, Research in Tobacco Related Illness, San Diego: Nov. 30, 2000.

"Restoring the risk to risk benefit analysis for cardiovascular disease," UC Irvine, Irvine, CA: Oct. 5, 2000.

"Gulf War Syndrome," UCSD Department of Medicine Grand Rounds, La Jolla, CA: Aug. 9, 2000. 

"Cardiovascular Prevention: Putting the Risk in Risk-Benefit."  UCSD course (to international group of physicians), Topics and Advances in Internal Medicine, La Jolla, CA: Feb. 11, 2000. 

"Medical Care: Restoring the Risk to Risk-Benefit Analysis," University of Chicago Health Sciences group; Chicago, IL: Feb. 8, 2000.

"Gulf War Illness," VASDHS Medicine Faculty Development series, La Jolla, CA: June 11, 1999.

"Aspirin for Primary Prevention of Coronary Artery Disease," Debate vs Dr. Leda Felicio. Dept of Medicine quarterly conference series, "Why Do We Do It?," VA San Diego Healthcare System, La Jolla, CA: March 26, 1999.

"Cholesterol and Violence: Where do we go from here?" Health Services Research and Development Seminar Series, San Diego VAMC/UC San Diego, La Jolla, CA: Feb. 11, 1999.

"Cholesterol and Violence," Colloquium, Social Science Research Institute, USC, Los Angeles, CA: Nov. 19, 1998.

"Cholesterol and Violence," Grand Rounds, Dept of Psychiatry, UC San Diego, La Jolla, CA: Nov 12, 1998.

Invited speaker and panelist: "How might interdisciplinary models of research guide us to a better understanding of violence?"  USC Interdisciplinary Perspectives for Understanding and Preventing Violence, co-sponsored by the Violence Prevention Coalition of Greater Los Angeles, Long Beach, CA: April 17, 1998.

"Cholesterol and Violence," Dept of Psychology Colloquium, UCSD, La Jolla, CA: April 16, 1998.

"Measurement and Management of Hyperlipidemia for the Primary Prevention of Coronary Heart Disease," with Dr. Michael H. Criqui.  Primary Care Grand Rounds, UCSD Dept of Family and Preventive Medicine, La Jolla, CA: April 15, 1998.

"The Cholesterol Controversy," VA San Diego Healthcare System quarterly "Why Do We Do It?" seminar, La Jolla, CA: March 29, 1997.

"Cholesterol and Violence: The Serotonin Connection," Mc Donnell Pew Research Center, Warner Springs Ranch, CA: March 15, 1997.

"Cholesterol and Violence," USC Dept. of Preventive Medicine, Los Angeles, CA: Feb 21, 1997

"The Cholesterol Controversy," San Diego VAMC, La Jolla, CA: Jan 10, 1997.

"Hyperlipidemia Panel Discussion"  Discussants: Alistair Fyfe, MD, PhD; B. Golomb, MD, PhD; David Heber, MD.  UCLA Department of Medicine Grand Rounds, Los Angeles, CA:  Aug 14, 1996.

"Cholesterol and Violence: Is There a Connection?"  RAND/UCLA Child and Adolescent Health Policy Seminar, RAND, Santa Monica, CA: July 9, 1996.

"Cholesterol and Violence: The Serotonin Connection," Telluride Summer Research Center Public Lecture, Telluride CO: July 5, 1996.

"Cholesterol and Violence: New Evidence," UCLA Health Services Research Seminar Series, Los Angeles, CA: June 21, 1996.

"Cholesterol Reduction: When is it Indicated?"  Cardiology Grand Rounds, Cedars Sinai Medical Center: June 18, 1996.

"Cholesterol, Serotonin, and Violence: Is there a Connection?," The Helmholtz Society, UC Irvine, Irvine, CA: June 11, 1996.

"Cholesterol Reduction in Primary Prevention: When is it Indicated?"  Cedars Sinai Medical Center, Health Services Research Group: March 6, 1996.

"Cholesterol Reduction: When and Who?"  St. Johns Medical Center, Santa Monica, CA: Nov 2, 1995.

"The Cholesterol Controversy," The Alzheimer Disease Research Consortium of Southern California, USC, Los Angeles, CA: April 21, 1995.

"Cholesterol Reduction in Primary Prevention," Debate vs Dr. David Leaf.  WLA VA Medical Center, Dept. of Medicine Grand Rounds, Los Angeles, CA: March 8, 1995.

"The Cholesterol Controversy," UCLA Dept. of Medicine Grand Rounds, Los Angeles, CA: Jan 11, 1995.

"Neural Networks Distinguish Demented Subjects from Elderly Controls based on EEGs," Neural Information Processing Systems conference, Neural Networks in Medicine workshop, Vail, CO: Dec. 3, 1994.

"Cholesterol Reduction in Primary Prevention: Rethinking the Evidence," UCLA Dept. of Endocrinology Grand Rounds, Los Angeles, CA: Sept. 21, 1994.

"Advance Directives," West Los Angeles VA Medical Center, Dept. of Medicine Conference, Los Angeles, CA: Sept. 16, 1994.

"The Cholesterol Myth," Grand Rounds, West Los Angeles V. A. Medical Center, Dept. of Medicine, Los Angeles, CA: June 8, 1994.

"Death by Hiccup," Reno V. A. Medical Center, Dept. of Medicine Conference, Reno NV: Feb. 1994.

"Hiccups," V. A. West Los Angeles Medical Center, Dept. of Medicine Conference, Los Angeles, CA: Jan. 1994.

"Neural Networks that Recognize Sex and Expressions from Faces," in international conference, Facial Expression: Brain, Perception, and Development, The Salk Institute, La Jolla, CA: April 6, 1991.

"SexNet: A neural network that distinguishes sex from face."  Neural Information Processing Systems, Spotlight presentation, Colorado: 1990.


PUBLICATIONS

RESEARCH PAPERS

Golomb BA, Evans, MA 2008 [in press]. "Statin Adverse Effects: A Review of the Literature & Evidence for a Mitochondrial Mechanism.” American Journal of Cardiovascular Drugs. 

Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH 2008 [in press]. “Reductions in Blood Pressure with Statins: Results from the UCSD Statin Study, a Randomized Trial.” Archives of Internal Medicine; 168(7).

Golomb BA 2008 [in press]. “Acetylcholinesterase Inhibitors and Gulf War Illnesses.” Proceedings of the National Academy of Science; 105(11): 4295-4300.

Golomb BA, McGraw JJ, Evans, MA, Dimsdale, JE 2007. "Physician Response to Patient Reports of Drug Adverse Effects: Implications for Patient-Targeted Adverse Effect Surveillance.” Drug Safety; 30(8): 669-675.

Golomb BA, Cortez-Perez M, Jaworski BA, Mednick SA, Dimsdale, JE 2007. “Point subtraction aggression paradigm: validity of a brief schedule of use.” Violence & Victims; 22(1): 95-103.

Golomb BA, Dang T, Criqui MH 2006. “Peripheral arterial disease: morbidity and mortality implications.” Circulation; 114: 688-699.

Wang JC, Criqui MH, Denenberg JO, McDermott MM, Golomb BA, Fronek A 2005 “Exertional leg pain in patients with and without peripheral arterial disease.” Circulation 112: 3501-8.

Golomb BA, Kane T, Dimsdale JE, 2004. "Severe irritability associated with statin cholesterol-lowering drugs." Quarterly J Med, 97:229-235.

Golomb BA, Criqui MH, White HL, Dimsdale JE 2004. "Study Design. The UCSD Statin Study: A randomized controlled trial assessing the impact of statins on noncardiac endpoints." Controlled Clinical Trials, 25:178-202.

Smythies J, Golomb BA, 2004. "Nerve gas antidotes," Journal of the Royal Society of Medicine, 97:32.

Golomb BA, Criqui MH, White HL, Dimsdale JE 2004. "Conceptual Foundations of the UCSD Statin Study: A Randomized Controlled Trial Assessing the Impact of Statins on Cognition, Behavior, and Biochemistry” Arch Intern Med; 164:153-162.

Criqui MH, Jamosmos M, Froniek A, Denenberg JO, Langer RD, Bergan J, Golomb BA 2003 Chronic venous disease in an ethnically diverse population: The San Diego Population Study.  Am J Epidemiol, 158:448-456.

Golomb BA, Tenkanen, L, Alikoski T, Niskanen T, Manninen V, Huttunen M, Mednick SA 2002. Insulin sensitivity markers: Predictors of accidents and suicides in Helskinki Heart Study screenees. Journal of Clinical Epidemiology, 55:1-7.

Bagley SC, White H, Golomb BA 2001.  "Use of logistic regression in the medical literature: Standard for use and reporting, with particular attention to one medical domain."  Journal of Clinical Epidemiology 54(10):979-985.

Golomb B, Vickrey G, & Hays RD 2001. "A review of health-related quality-of-life measures in stroke." Pharmacoeconomics, 19: 155-185.

Golomb BA, Stattin H, Mednick SA 2000.  "Low cholesterol and violent crime." J Psychiatric Res 34: 301-309.

Golomb BA, Pyne JM, Jaworski BA, Wright B, Lohr JM, Bozzette SA 2000.  "Primary care for patients with severe mental illness: What role can psychiatrists play?" Psychiatric Services 51(6): 766-773.

Golomb BA, Criqui MH, Detrano RC, Wong ND, Bundens WP, Mattrey RF, Denenberg JO 1999.  "Noninvasive testing to detect subclinical cardiovascular disease.  What is its role?" Preventive Cardiology 2(4):42-50 (Fall supplement).

Golomb BA 1998. "Low cholesterol and violence: Is there a connection?" Annals of Internal Medicine, 128:478-487.

Criqui MH, Golomb BA 1998.  "Epidemiologic aspects of lipid abnormalities."  American Journal of Medicine, 105 (1A): 48S-57S.

Stewart-Bartlett M, Viola PA, Sejnowski TJ, Golomb BA, Larsen J, Hager JC and Ekman P 1996 "Classifying facial action." Advances in Neural Information Processing Systems  8: 823-829.

Gray MS, Lawrence DT, Golomb BA and Sejnowski TJ 1995. "A perceptron reveals the face of sex." Neural Computation, 7(6)1160-64.

Golomb BA, Lawrence DT, and Sejnowski TJ 1991. "SexNet: A neural network that recognizes sex from human faces." Advances in Neural Information Processing Systems 3, 572-577. 

Golomb BA, Andersen RA, Nakayama K, MacLeod DIA, Wong A 1985. "Visual thresholds for shearing motion in monkey and man." Vision Research 25, 813-820.


EDITORIALS, INVITED PAPERS, OTHER

Golomb BA 2007 “Reasoning from evidence. A call for education.”  Invited contribution to: Edge.org “What have you changed your mind about?” http://www.edge.org/q2008/q08_15.html#golomb

Golomb B 2007 “Odile reminiscences”, Odile Crick Memorial Exhibition, Edited by Becky Cohen, published by Salk Institute, p 23-24, 45.

Golomb BA 2006. “Reforming scientific and medical publishing via the internet.”  Invited contribution to: Edge.org “What are you optimistic about?” 

Abbreviated version: http://edge.org/q2007/q07_15.html#golomb http://edge.org/q2007/q07_15.html#golomb 

Full version: http://www.tsntv.org/articles/Golomb_Edge2007_expanded.pdf  

See also Book Chapters (abbreviated version later published)

Golomb BA 2005. “Statins and Blood Pressure a Probable Link?” http://www.audiomedica.com/?p=52. Audio Journal of Cardiovascular Medicine, 11:1. 

Golomb BA 2005. “Impact of statin adverse events in the elderly.” Expert Opinion on Drug Safety 4(3):389-397.

Criqui MH and Golomb BA 2004. “Low and lowered cholesterol and total mortality.” J Am Coll Cardiol 44(5): 1009-10.

Golomb BA 2004. “Statin side effects. Implications for the elderly.” Geriatric Times May/June, 18-20.

Criqui MH and Golomb BA 1999. "Should patients with diabetes drink to their health?" Journal of the American Medical Association 282 (3):279-80.

Golomb B and Criqui M 1999. "Anti-hypertensives: Much Ado About Lipids." Archives of Internal Medicine, 159: 535-537.

Golomb B 1998. "Dietary Fats and Heart Disease: Dogma Challenged." Journal of Clinical Epidemiology 51(6): 461-464.

Golomb BA 1995. "Are Placebos Bearing False Witness?” Chemistry and Industry 21: 900.


BOOKS

Golomb BA  A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol 3: Immunizations RAND.  Unreleased.

Cecchine G, Johnson D, Perry W, Anthony C.R., Golomb B, Hearn A.C., Hilborne  L, Sollinger J. 2001. Army Medical Support to the Army After Next. RAND. 80 pages.

Hilborne LH, Golomb BA 2001. A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol 1: Infectious Diseases.  RAND, Santa Monica, CA.  119 pages. Peer reviewed book.

Cecchine G, Golomb BA, Hilborne LH, Spektor DM, Anthony RA 2000: A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol 8: Pesticides RAND, Santa Monica. 182 pages. Peer reviewed book.

Golomb BA 1999. A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol 2: Pyridostigmine Bromide. Washington, DC, RAND 385 pages.  Peer reviewed book. (Among top 10 best selling RAND books in 2000 list).


BOOK CHAPTERS

Golomb BA, Criqui MH 2008 in press. "Epidemiology of PAD."  In: MA Creager (Ed.), Management of Peripheral Arterial Disease.  ReMedica Publishing, London.  In press

Golomb B 2007 Reforming Scientific and Medical Publishing Via the Internet.” In: What Are You Optimistic About? Today's Leading Thinkers on Why Things Are Good and Getting Better,” John Brockman (Ed.), Harper Collins, New York. p 346-350.

Golomb BA, Criqui MH, Bundens WP 2001. "Epidemiology of peripheral arterial disease."  In: MA Creager (Ed.), Management of Peripheral Arterial Disease: Medical, Surgical and Interventional Aspects.  ReMedica Publishing, London. p 1-18.

Golomb BA, Criqui MH, Bundens WP 2001. "Peripheral arterial disease."  In Hiatt, W.R., Hirsch, A.T., Regensteiner, J. (Eds), Peripheral Arterial Disease Handbook. CRC Press, Boca Raton, pp. 57-80.

Golomb B 2000.  "Health and Medical Factors: Cholesterol."  In: Violence in America - An Encyclopedia, Charles Scribner’s Sons.

Golomb BA 2000.  "Cerebrovascular disease." In Kerr EA, Asch SM, Hamilton EG, McGlynn EA  (Eds.) Quality of Care for Cardiopulmonary Conditions: A Review of the Literature and Quality Indicators. RAND Health, Santa Monica: Pp 69-90.

Golomb BA 2000. "Chronic obstructive pulmonary disease." In Kerr EA, Asch SM, Hamilton EG, McGlynn EA (Eds.) Quality of Care for Cardiopulmonary Conditions: A Review of the Literature and Quality Indicators.   RAND Health, Santa Monica:  Pp 91-116.

Golomb BA 2000. "Hyperlipidemia."  In Kerr EA, Asch SM, Hamilton EG, McGlynn EA  (Eds.) Quality of Care for Cardiopulmonary Conditions: A Review of the Literature and Quality Indicators.   RAND Health, Santa Monica: Pp 201-216.

Golomb BA 2000. "Dyspepsia and Peptic ulcer disease." In Kerr EA, Asch SM, Hamilton EG, McGlynn EA  (Eds.) Quality of Care for General Medical Conditions A Review of the Literature and Quality Indicators.  RAND Health:  Pp 263-290.

Golomb B and Sejnowski TJ 1995. "Sex recognition from faces using neural networks."  In: AF Murray (Ed.), Applications of Neural Networks, Kluwer Academic Publishers.


TECHNICAL REPORTS AND RAND REPORTS (see also Books)

Binns JH, Cherry N, Golomb BA, et al. Research Advisory Committee on Gulf War Veterans' Illnesses: Scientific Progress in UnderstandingGulf War Veterans’ Illnesses: Report and Recommendations. http://www1.va.gov/rac-gwvi/docs/ReportandRecommendations_2004.pdf; 2004 September 2004.

Golomb BA 2003. Research Recommendations. Written brief for Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses.

Golomb BA, Pickett D 2003. Surveillance for birth defects in ill Gulf War veterans. Written brief for Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses.

Golomb BA. 2002. Acetylcholinesterase inhibitor effects: Neurological and nonneurological mechanisms. Written brief for Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses.

Golomb BA. 2002. Mitochondrial dysfunction. A mechanism of illness in Gulf War veterans? Written brief for Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses.

Golomb BA, Chadwick A. 2002. Treatment considerations for ill Gulf War veterans. Written brief for Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses.

Golomb BA, Haley R 2002. Objective Markers: Means to Identify Mechanisms and Treatments in Gulf War veterans. Written brief for Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses.

Golomb B 1999.  Assessing the Care of Vulnerable Elders.  Potential Quality Indicators and Literature Review: Stroke.  RAND report. 113 pages.

Perry W, Johnson D, Cecchine G, Golomb B, Hilborn L, Hearn A, Anthony R 1999.  Issues and Insights from the Army Medical Technology Workshop, 1999. Prepared for the US Army Training and Doctrine Command and the US Army Medical Department.  RAND report PM-946-A, July 1999.

Hays RD, Vickrey BG, Golomb B "Health related quality of life measures in studies of stroke." RAND report, July 1997.

Sherbourne CD, Golomb BA, Bystritsky A, Inkeles M, Marshall G. "Summary of Health-related Quality of Life Measures for Use in Anxiety Disorders." RAND report, July 1997.

Gray MS, Lawrence DT, Golomb BA and Sejnowski TJ 1993.  "A perceptron reveals the face of sex." Institute for Neural Computation Technical Report Series, INC-9303.


LETTERS TO THE EDITOR

Golomb BA, Evans MA 2008 [in press]. “Less Neurodegeneration in Statin Users: Association Not ‘Effect.’ ” Neurology.

Golomb BA, Mednick SA, Tenkanen L 2007. “Suicide: A Weighty Matter?” Arch Internal Med 167 (17): 1908.

Golomb BA, Evans MA 2007. “Potential Link Between HMG-CoA Reductase Inhibitor (Statin) Use and Interstitial Lung Disease.” Med J Australia 187 (4): 253.

Golomb BA, Evans MA 2006. “Risk Factors for Rhabdomyolysis with Simvastatin and Atorvastatin.” Drug Safety 29 (12): 1191.

Golomb BA 2002. "When are medication side effects due to the nocebo phenomenon?" JAMA 287: 2502-3; discussion 2503-4.

Kaplan RM, Golomb BA 2001. "Cost-effectiveness of statin medications." Am Psychol. 2001 Apr;56(4):366-7.

Golomb BA and Jaworski BA 2001. "Statins and Dementia." Archives of Neurology 58: 1169-70.

Golomb BA 1998. "Cholesterol and violence: Is there a connection?" Annals of Internal Medicine 129(8): 669-670.

Golomb BA 1996. "Low serum cholesterol and serotonin metabolism -- other studies have been done in humans and monkeys."  BMJ 312(7041):1299.

Golomb BA 1996. "Using placebos," Nature 379: 765.

Golomb BA 1995. "Low cholesterol and violence," Arch Intern Med 155: 2485.

Golomb BA 1995. "Paradox of placebo effect," Nature 375: 530.

Golomb B 1990. "Hiccup for hiccups," Nature 345: 774.

Golomb B 1989. "Taking a byte out of time," JAMA 262: 3132.


BOOK REVIEWS

Golomb BA 1997. "Catalyst -- For Change in Book Reviews," Chemistry and Biology 4: 651-652.

Golomb BA 1996. "Genius talk or moron babble?  The complementarity principle," Chemistry and Biology 3: 813-814.

Golomb BA 1995. "Author's Imagination" (Review of Nature's Imagination: The Frontiers of Scientific Vision), Chemistry and Biology 2(10): 651-2.


THESIS

Golomb BA 1988. "Visual Motion Processing: Some Special Properties," PhD Thesis, Department of Biology, U. C. San Diego.


ABSTRACTS 

Golomb BA, Evans MA, Dimsdale JE 2008 [in press]. “Trans Fat Consumption Linked to Aggression.” Poster presentation/abstract, American Heart Association Nutrition, Physicial Activity & Metabolism Conference, Colorado Springs, CO: March 12, 2008.

Golomb BA, Dimsdale JE, Evans MA, Denenberg JO, White HL, Criqui MH 2008 [in press]. “Effects of Statins on Aggression Differ by Gender: Results of a Double Blind Placebo Controlled Trial.” Poster presentation/abstract, American Heart Association 48th Cardiovascular Disease Epidemiology and Prevention Annual Conference, Colorado Springs, CO: March 13, 2008.

Golomb BA, Kwon EK, Criqui MH, Dimsdale JE 2007. “Simvastatin But Not Pravastatin Affects Sleep: Findings from the UCSD Statin Study.” Circulation supplement; 116:II-847.

R Yaghmai; MJ Renvall; BA Golomb; LA Lenert; JW Ramsdell 2007. “An Epidemic Of Musculoskeletal Symptoms Among Physicians In Two Institutions Using EMR-Based Systems For Routine Care.” Poster presentation/abstract, Society of General Internal Medicine meeting, Toronto, Canada: April 25-28, 2007.

Golomb BA, Dimsdale JE, White HL, Criqui MH 2006. “Do Low Dose Statins Affect Cognition? Results of the UCSD Statin Study.” Circulation supplement; 114(18): II-289.

Golomb BA, McGraw J 2005. "Lack of Physician Response Toward Perceived Statin Adverse Events." Circulation supplement.

Golomb BA, Ritchie JB, Criqui MH, Dimsdale JE. 2004. Statins Lower Blood Pressure: Results from the UCSD Statin Study. Circulation (suppl 3) 110(17): 402.

Kordas K, Phillips P, Golomb B 2004. Clinical Characteristics of 1053 Patients with Statin-Associated Muscle Complaints. Arterioscler Thromb Vasc Biol; 24:e51-136.

Golomb BA, Yang E, Denenberg J, Criqui MH 2003. "Statin Associated Muscle Adverse Effects." Poster presentation/abstract, AHA Council on Epidemiology and Prevention meeting, Miami FL: March 7, 2002.

Yang E, Jaworski B, Denenberg J, Criqui MH, Golomb BA 2002. Muscle symptoms in patients on statins. American Heart Association Young Investigators Forum, San Diego, CA: Sept. 2002.

Golomb, BA 1999. "Could dysregulation of acetylcholine (from pyridostigmine bromide or other acetylcholinesterase inhibitors) contribute to illness in Persian Gulf War veterans?" Conference on Federally Sponsored Gulf War Veterans’ Illnesses Research, June 23-25, 1999 (Abstract accepted; withdrawn for security reasons at request of DoD).

Golomb BA and Criqui MH 1998. "Put the risk back in risk-benefit," 1998 San Diego Biostatistics & Epidemiology Research Exchange Conference. La Jolla, CA (Platform presentation May 5, 1998).

Bagley S and Golomb BA 1998. "Patient interest and response to genetic testing for cancer susceptibility: A systematic review of the literature," American Federation for Medical Research, Western Regional Meeting, Feb 4-7, 1998, Carmel, CA.  J Investigative Medicine 46(1).

Pyne J, Golomb B, Schten E, Jaworski B, Bozzette S 1998. "Appropriate roles for psychiatrists delivering primary medical care," VA HSR&D meeting, Feb 1998.

Golomb BA 1996. "Low cholesterol and Violent Crime," Proceedings of the Robert Wood Johnson Clinical Scholars Program 24th National Meeting, Ft. Lauderdale, FL. (Platform presentation: Nov 1996).

Golomb BA 1995. "Cholesterol, serotonin, and violence: Is there a connection?" Proceedings of the Robert Wood Johnson Clinical Scholars Program 23rd National Meeting, Ft. Lauderdale, FL. (Platform presentation: Nov 9, 1995).

Golomb B and Leuchter AF 1993. "Neural Networks Distinguish Demented Patients from Elderly Controls Based on EEG Recordings," Solomon Scholar Research Award, UCLA. (Platform presentation: June 1993).

Golomb B, Lawrence D, Sejnowski T, and Ekman P 1992. "Neural Networks Evaluate Facial Muscle Actions," Solomon Scholar Research Award, UCLA, 1992. (Platform presentation, June 1992).

Golomb B 1990. "Cross adaptation to flow field motion," Investigative Ophthalmology and Visual Science 31 (4):522.  Poster presentation, Association for Research in Vision and Ophthalmology, Sarasota, FL, April 1989.

Golomb B 1988. "Motion Escape," Investigative Ophthalmology and Visual Science 29.  Poster presentation, Association for Research in Vision and Ophthalmology, Sarasota, FL, April 1988.

Golomb B 1986. "The Crankshaft Effect," Investigative Ophthalmology and Visual Science 27(3): 345.  Poster presentation, Association for Research in Vision and Ophthalmology, Sarasota, FL, April 1986.

Golomb B, Andersen, RA, Nakayama, K, MacLeod, DIA, Wong, A. 1984. "Thresholds for shearing motion detection in monkey and man," Investigative Ophthalmology and Visual Science 25(3):69. Poster presentation, Association for Research in Vision and Ophthalmology, Sarasota, FL, April 1984.


MEDIA INTEREST (selective)

Statin Adverse Effect website:

Wall Street Journal. “Researchers Ask Patients to Hell Fill Gap in Data on Side Effects of Statins.” Tara Parker-Pope. 10/3/2006; 

United Press International. “Statin Users Report Side Effects Online.” Leah Carliner. 9/22/2006; Channel 10 television news, San Diego, Carol LeBeau; (Numerous small publications)

 SignOn SanDiego.com. “Trouble With Statins? Tell UCSD.” Lamb, Kevin. 10-31-2006

.ABC7 News.com. Risks & Benefits of Statin Drugs.” Dr. Dean Edell Health column. 2/11/2007

Washington Post Online, Reuters Online, MSNBC Online, KPBS, AMedNews.com. “Docs Often Write off Patient Side Effects.”  10/1/2007

 American Heart Association, WebMD, Health Day, Fox News, LA Times. “Cholesterol-lowering drug linked to sleep disruptions.” 

The New York Times. “Data about zetia risks was not fully revealed.” Dec 21, 2007. 

The New York Times. “Can Statins Make You Stupid?” Tara Parker-Pope. 2/13/2008.


Cholesterol; and Statin risk-benefit:

11-97 KNBC TV;  3-98 New York Times 5 column article, CNN, NBC, ABC, CBS, LA Times, Reuters/AP, Science magazine. Also, British newspapers. 

NBC Nightly News, 8-24-01. NBC Nightly News, 11-13-01. Wall Street Journal, 4-25-02.  MSNBC (print) 8-24-01.Wall Street Journal, 12-02. San Diego Union Tribune 5-03. Los Angeles Times 7-03. Wall Street Journal 1-04. New York Times 7-04. CBS News with Dan Rather 5-04.  Newsday 7-04.  The San Diego Union Tribune 7-04. The Times (London) 8-04.

     Other: Multiple newspapers throughout US 7-00, 9-00; healthcentral.com 7-00; 10-00. People’s Pharmacy, LA Times, 2000 & 2001. Public radio (with Peoples Pharmacy), 4-7-01 (nationally syndicated). Florida News 5-01. San Diego Union Tribune, 5-16-01 & 5-28-01 (front page article); Philadelphia Enquirer 8-27-01. Sciences et Avenir (France), 10-01. WebMD (peripheral neuropathy) 5-02. Discover magazine. KPBS radio 5-29-02 10-11 "These Days"; with Tom Fudge and Dr. Michael Criqui; UCSD TV, lecture 8-02. Men's Health, San Francisco Chronicle 1-05. The Sunday Times-Britain 3-05. San Diego Union Tribute 7-05. Lifetime Fitness 12-05. Daily News (UK) 6-06. Daily Mail (UK) 6-06. BusinessWeek 8-06. Daily Mail (UK) 1-07. ABC7News.com 2-07.

The New York Times. “Great Drug, but Does It Prolong Life?” Tara Parker-Pope. 1/29/2008

Ladies' Home Journal. “Does Cholesterol Really Count?” Linda Marsa. Feb-08

The Wall Street Journal. “Can a Drug That Helps the Heart be Harmful to the Brain?” Melinda Beck. 2/12/2008.

 

Gulf War illness, 

Following Pentagon press briefing 10-99 (and interviews)

NY Times and LA Times (front page of each); Washington Post, San Diego Union Tribune, multiple other newspapers; NPR, other radio stations, national TV news on ABC and CBS (lead story), NBC; CNN, CSPAN; policy.com, Yahoo (lead news story), lead Headline News story on The Daily Show with Jon Stuart; science journals including New Scientist. BBC radio interview, BBC television, television news throughout Western Europe (e.g. Britain, Germany, other), Eastern Europe, Australia; newspapers and news magazines throughout same distribution (10-99) -- e.g. Le Monde (France), Hungarian newspapers and news magazines, Danish periodicals, German, BBC news

Following Congressional testimony in 11-99: CNN. 

Subsequent: Science magazine 4-01. Science magazine 4-02. NPR Science Friday (radio guest), 3-03.

On release of Committee report: Front page article NY Times 10-15-04; Front page San Diego Union Tribune 10-15-04; BBC radio 10-15-04 (or 10-16); London Times; Others internationally.;Science Magazine; BMJ (news section); BBC News (and BBC radio) 10-04.  BMJ News Extra 10-04.   

“Study: Sarin at Root of Gulf War Syndrome.” Kelly Kennedy. Army Times. 5/25/2007


Pyridostigmine FDA approval 3-03: Science magazine, multiple regional papers (e.g. Rocky Mountain Times, Orange County Register)


Cholesterol and violent crime, Web MD 2000; Clinical Pearls 2001; Crime Times 2001


Alcohol and diabetes, re: JAMA article: 7-99: Fox News, Science News, other 


Neural networks, pertaining to SexNet and ExpressionNet: 1990 CNN; 1990 Jim Jubek, In the Image of the Brain (Popular book on neural network revolution); 1992, The Machine that Changed the World, Episode 4: The Thinking Machine (A PBS NOVA Documentary).